Phentolamine: all 38 studies that test it
Page 1 of 1. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.
- OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual AcuityRecruitingNCT07140783Phase 3
- Sympathetic Vascular Transduction Across the Menopause Transition: Contributing MechanismsRecruitingNCT06787066Early Phase 1
- Pre-operative Phentolamine Vs Intraoperative Esmolol Efficacy for Hypotensive Anesthesia in Functional Endoscopic Sinus SurgeryNot yet recruitingNCT06620991Not applicable
- Intravenous Labetalol vs Phentolamine for the Management of Severe Preeclampsia.Not yet recruitingNCT06385600Not applicable
- Efficacy of Phentolamine in Prevention of Contrast-Associated Acute Kidney Injury After Complex PCIRecruitingNCT06286059Phase 2/3
- New Perspective on Exploring the Post-apneic BP Surge in Patients With OSARecruitingNCT06172998Early Phase 1
- Sympathetic Neurovascular Transduction: Role of Adrenergic Receptors and Sex DifferencesRecruitingNCT05997732Phase 4
- Effectiveness of Phentolamine Mesylate as a Reversing Agent for Local Anesthesia in ChildrenRecruitingNCT05448807Phase 3
- Sex Disparities in Hypoxic Vasodilation and Impact of ObesityRecruitingNCT05219799Early Phase 1
- : Vascular Function in Health and DiseaseRecruitingNCT02966665Phase 1
- Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With PresbyopiaCompletedNCT06542497Phase 3Results posted
- Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual DisturbancesCompletedNCT06349759Phase 3Results posted
- Safety and Efficacy of Nyxol Eye Drops as a Single Agent and With Adjunctive Low-Dose Pilocarpine Eye Drops in Subjects With PresbyopiaCompletedNCT05646719Phase 3Results posted
- Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis in Pediatric SubjectsCompletedNCT05223478Phase 3Results posted
- Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis (MIRA-3)CompletedNCT05134974Phase 3Results posted
- Safety and Efficacy of Nyxol With Pilocarpine Eye Drops in Subjects With PresbyopiaCompletedNCT04675151Phase 2Results posted
- Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) in Subjects With Dim Light Vision DisturbancesCompletedNCT04638660Phase 3Results posted
- Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced MydriasisCompletedNCT04620213Phase 3Results posted
- Safety and Efficacy of Ophthalmic Phentolamine Mesylate to Reverse Pharmacologically Induced MydriasisCompletedNCT04024891Phase 2Results posted
- Single Dose Study of Phentolamine Mesylate Eye Drops in Patients With Severe Night Vision DisturbancesCompletedNCT04004507Phase 2Results posted
- Safety and Efficacy of Ophthalmic Phentolamine Mesylate in GlaucomaCompletedNCT03960866Phase 2Results posted
- Adrenergic System in Islet TransplantationCompletedNCT03079921Early Phase 1Results posted
- The Safety and Efficacy of Phentolamine Mesylate Ophthalmic Solution in Subjects With Severe Night Vision DisturbancesCompletedNCT01703559Phase 2Results posted
- The Role of the Adrenergic System in Hypoglycaemia Induced Inflammatory Response in People With Type 1 Diabetes and People Without Type 1 Diabetes-RAID-IICompletedNCT06422494Not applicable
- Sex Differences in Sympathetic Vascular Reactivity at High AltitudeCompletedNCT05525416Not applicable
- Phentolamine Mesylate vs. Diode Laser for Anaesthesia ReversalCompletedNCT05473858Phase 3
- Phentolamine Mesylate as a Reversal of Local AnesthesicsCompletedNCT03740386Not applicable
- Role of Sympathetic Vasoconstriction on Insulin-Mediated Microvascular Recruitment and Glucose Uptake in ObesityActive, not recruitingNCT03318094Phase 1
- A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular SystemsTerminatedNCT03098680Phase 1
- Reversing the Effects of 0.5% BupivacaineCompletedNCT02995291Phase 4
- Reversing the Effects of 2% LidocaineCompletedNCT02861378Not applicable
- Study of OraVerse® for Safety and Efficacy in Pediatric Dental PatientsCompletedNCT01474382Phase 4
- Study of NV-101 for Efficacy, Pharmacodynamics, and Safety in Dental Patients Undergoing Mandibular ProceduresCompletedNCT00309361Phase 3
- Study of NV-101 for Efficacy, Pharmacodynamics, and Safety in Dental Patients Undergoing Maxillary ProceduresCompletedNCT00309335Phase 3
- Study of NV-101 for Safety and Efficacy in Pediatric Dental Patients Undergoing ProceduresCompletedNCT00309322Phase 2
- Safety and Efficacy Study of NV-101 in Dental PatientsCompletedNCT00154167Phase 2
- The Effect of Alfa-Adrenergic Receptor Blockade on Insulin-Stimulated Forearm Glucose Uptake and Metabolism in Chronic Heart FailureStatus unknownNCT00132106Not applicable
- Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate CancerCompletedNCT00080808Phase 2